|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | |
| A61K 38/22 | |||
| A61K 47/68 | |||
| C07K 14/44 | |||
| C07K 14/195 | |||
| A61P 5/00 |
| (11) | Patento numeris | 3411062 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17748111.6 |
| Europos patento paraiškos padavimo data | 2017-02-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-12-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/016120 |
| Data | 2017-02-02 |
| (87) | Numeris | WO 2017/136492 |
| Data | 2017-08-10 |
| (30) | Numeris | Data | Šalis |
| 201662290202 P | 2016-02-02 | US |
| (72) |
LIU, Yang, US
ZHENG, Pan, US
DEVENPORT, Martin, US
|
| (73) |
Oncoimmune Inc.,
9430 Key West Avenue Suite 113, Rockville, Maryland 20850,
US
|
| (54) | USE OF CD24 PROTEINS FOR TREATING LEPTIN-DEFICIENT CONDITIONS |
| USE OF CD24 PROTEINS FOR TREATING LEPTIN-DEFICIENT CONDITIONS |